Pfiz­er sells off par­tial stake in Ha­le­on, po­ten­tial­ly rais­ing $2B+

Fol­low­ing in GSK’s foot­steps, Pfiz­er is sell­ing off about 630 mil­lion shares of its stake in con­sumer health spin­off Ha­le­on, re­duc­ing the Big Phar­ma’s stake …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.